Abstract
There are several reasons to anticipate alterations in the pharmacokinetic (PK) characteristics of medications following bariatric surgery. Approximately 40% of bariatric surgery candidates are taking an antidepressant medication prior to surgery and the majority of patients continue to take them following surgery. Therefore, potential PK alterations in antidepressant and other psychotropic medications following surgery are important to consider, as they may affect their efficacy and tolerability.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
